Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for GH Research PLC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 8:34 pm Sale |
2023-12-31 | 13G | GH Research PLC GHRS |
Venrock Healthcare Capital Partners II, L.P. | 1,318,327 2.500% |
-2,198,798 (-62.52%) |
Filing |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | GH Research PLC GHRS |
Venrock Healthcare Capital Partners II, L.P. | 3,517,125 6.800% |
696,624 (+24.70%) |
Filing |
| 2022-05-27 4:05 pm Purchase |
2022-05-17 | 13G | GH Research PLC GHRS |
Venrock Healthcare Capital Partners II, L.P. | 2,820,501 5.400% |
2,820,501 (New Position) |
Filing |